Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-08

Clinical Trial Update: Vortioxetine in Patients With Depression and Early Dementia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of vortioxetine in patients with major depressive disorder and dementia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder, Dementia | Phase 4 | Status: COMPLETED